uk parliamentary yearbook, page-10

Hi livas1,

I wouldn't expect that there will be an ann. at the completion of the 4 week monitoring period. No news is good news in this case, because it indicates that there have been no negative reactions in the patients dosed. Under the trial condition they are required to notify as soon as a negative reaction is seen.

The only other thing that I can think of that may result in an announcement, in this case, is if EMS wants to start spruiking it's book, to get the oppies in the money by end of December?

I sort of hope that all the activity of late is based on fundamentals associated with PhIII trial completion and not a concerted pump to get the oppies in,time will tell I guess?

I expect that current funds held by EMS are sufficient for publication of results and registration of ArTiMist in relevant countries but really have no idea what these things cost.

bluebush

bluebush